| Breaking: Microsoft Engineers Give Nod to Next Big AI Player (ad) |
|
| What is Nvidia's New $1 Trillion Superproject? (ad) |
|
 Apple Inc. (AAPL)    Amazon.com, Inc. (AMZN)   Barker Minerals Ltd (BML) - No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
 Meta Platforms, Inc. (META)   Microsoft Co. (MSFT)  - Ameren (NYSE:AEE) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $77.00 price target on the stock, up previously from $73.00. This represents a 8.7% upside from the current price of $70.86.
- C3.ai (NYSE:AI) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $35.00 price target on the stock. This represents a 23.6% upside from the current price of $28.31.
- Alignment Healthcare (NASDAQ:ALHC) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $11.00 price target on the stock, up previously from $7.75. This represents a 42.5% upside from the current price of $7.72.
- Datadog (NASDAQ:DDOG) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $155.00 price target on the stock, up previously from $143.00. This represents a 29.9% upside from the current price of $119.34.
- Ero Copper (NYSE:ERO) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating.The current price is $21.81.
- Formula One Group (NASDAQ:FWONA) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $83.00 price target on the stock, up previously from $73.00. This represents a 21.2% upside from the current price of $68.48.
- Corning (NYSE:GLW) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $43.00 price target on the stock, up previously from $37.00. This represents a 18.3% upside from the current price of $36.35.
- Hallador Energy (NASDAQ:HNRG) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $9.00 price target on the stock, up previously from $8.00. This represents a 9.8% upside from the current price of $8.20.
- International Game Technology (NYSE:IGT) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock, up previously from $24.00. This represents a 34.3% upside from the current price of $19.36.
- Lifeway Foods (NASDAQ:LWAY) was upgraded by analysts at Noble Financial from a "market perform" rating to an "outperform" rating. They now have a $20.00 price target on the stock. This represents a 19.3% upside from the current price of $16.77.
- Okta (NASDAQ:OKTA) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $122.00 price target on the stock, up previously from $102.00. This represents a 35.0% upside from the current price of $90.38.
- PayPal (NASDAQ:PYPL) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock, up previously from $68.00. This represents a 42.5% upside from the current price of $63.14.
- USA Compression Partners (NYSE:USAC) was upgraded by analysts at Mizuho from an "underperform" rating to a "neutral" rating. They now have a $26.00 price target on the stock, up previously from $23.00. This represents a 7.9% upside from the current price of $24.10.
- United States Cellular (NYSE:USM) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $75.00 price target on the stock, up previously from $38.00. This represents a 53.8% upside from the current price of $48.77.
- View today's most recent analysts' upgrades at MarketBeat.com
| What Wall Street is doing while you're at dinner… (ad) |
|
- Advanced Health Intelligence (NASDAQ:AHI) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating.The current price is $1.50.
- Atlantica Sustainable Infrastructure (NASDAQ:AY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $22.00 price target on the stock, down previously from $25.00. This represents a 1.4% downside from the current price of $22.31.
- CAVA Group (NYSE:CAVA) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $92.00 price target on the stock, up previously from $63.00. This represents a 0.9% downside from the current price of $92.85.
- Ciena (NYSE:CIEN) was downgraded by analysts at Rosenblatt Securities from a "buy" rating to a "neutral" rating. They now have a $52.50 price target on the stock, down previously from $65.00. This represents a 10.2% upside from the current price of $47.66.
- Ecopetrol (NYSE:EC) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.The current price is $12.35.
- FactSet Research Systems (NYSE:FDS) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $407.00 price target on the stock, down previously from $500.00. This represents a 0.4% downside from the current price of $408.47.
- Generac (NYSE:GNRC) was downgraded by analysts at Guggenheim from a "neutral" rating to a "sell" rating. They now have a $120.00 price target on the stock. This represents a 18.6% downside from the current price of $147.41.
- Noah (NYSE:NOAH) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $13.00 price target on the stock, down previously from $18.00. This represents a 20.8% upside from the current price of $10.76.
- Nutanix (NASDAQ:NTNX) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $71.00 price target on the stock. This represents a 22.2% upside from the current price of $58.09.
- UiPath (NYSE:PATH) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $11.82.
- Pure Storage (NYSE:PSTG) was downgraded by analysts at Northland Securities from an "outperform" rating to a "market perform" rating. They now have a $68.00 price target on the stock, up previously from $58.00. This represents a 8.2% upside from the current price of $62.85.
- View today's most recent analysts' downgrades at MarketBeat.com
| $5k to $1.3m in just 3 trades (ad) |
It doesn't happen often, but occasionally, something completely unique comes across my radar.
In this case, I'm talking about legal "Insider Trading".
Traders who have consistently signaled 453% … 610% .. and even 1036%... gains.
And until now they have been doing it completely under the radar.
In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
Register for the imminent briefing here. |
|
- Abeona Therapeutics (NASDAQ:ABEO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $21.00 price target on the stock. This represents a 388.4% upside from the current price of $4.30.
- Abbott Laboratories (NYSE:ABT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $121.00 price target on the stock. This represents a 18.2% upside from the current price of $102.39.
- Adaptimmune Therapeutics (NASDAQ:ADAP) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $3.15 price target on the stock. This represents a 213.4% upside from the current price of $1.01.
- ADC Therapeutics (NYSE:ADCT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.The current price is $3.34.
- agilon health (NYSE:AGL) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $6.00 price target on the stock. This represents a 2.6% downside from the current price of $6.16.
- Alignment Healthcare (NASDAQ:ALHC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $10.00 price target on the stock. This represents a 29.5% upside from the current price of $7.72.
- Astrana Health (NASDAQ:ASTH) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $54.00 price target on the stock. This represents a 35.3% upside from the current price of $39.91.
- AstraZeneca (NASDAQ:AZN) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $97.00 price target on the stock. This represents a 26.4% upside from the current price of $76.72.
- Baxter International (NYSE:BAX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $36.00 price target on the stock. This represents a 7.4% upside from the current price of $33.53.
- Bayer Aktiengesellschaft (OTCMKTS:BAYRY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating on the stock.The current price is $7.31.
- Becton, Dickinson and Company (NYSE:BDX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $274.00 price target on the stock. This represents a 21.4% upside from the current price of $225.61.
- Boston Scientific (NYSE:BSX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $90.00 price target on the stock. This represents a 19.6% upside from the current price of $75.27.
- Codexis (NASDAQ:CDXS) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $11.00 price target on the stock. This represents a 222.6% upside from the current price of $3.41.
- The Cigna Group (NYSE:CI) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $388.00 price target on the stock. This represents a 16.5% upside from the current price of $333.00.
- Centene (NYSE:CNC) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $83.00 price target on the stock. This represents a 19.1% upside from the current price of $69.68.
- Chesapeake Utilities (NYSE:CPK) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $111.00 price target on the stock. This represents a 2.9% upside from the current price of $107.87.
- CVS Health (NYSE:CVS) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $61.00 price target on the stock. This represents a 11.1% upside from the current price of $54.92.
- DexCom (NASDAQ:DXCM) is now covered by analysts at Redburn Atlantic. They set a "neutral" rating and a $130.00 price target on the stock. This represents a 3.0% upside from the current price of $126.20.
- Elevance Health (NYSE:ELV) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $649.00 price target on the stock. This represents a 27.0% upside from the current price of $510.87.
- Edwards Lifesciences (NYSE:EW) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $107.00 price target on the stock. This represents a 20.8% upside from the current price of $88.59.
- Forte Biosciences (NASDAQ:FBRX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $4.00 price target on the stock. This represents a 605.0% upside from the current price of $0.57.
- Amicus Therapeutics (NASDAQ:FOLD) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 85.0% upside from the current price of $9.73.
- GE HealthCare Technologies (NASDAQ:GEHC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $87.00 price target on the stock. This represents a 12.1% upside from the current price of $77.63.
- GSK (NYSE:GSK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $47.00 price target on the stock. This represents a 6.7% upside from the current price of $44.04.
- HCA Healthcare (NYSE:HCA) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $396.00 price target on the stock. This represents a 18.5% upside from the current price of $334.28.
- Humana (NYSE:HUM) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $374.00 price target on the stock. This represents a 6.4% upside from the current price of $351.36.
- Inozyme Pharma (NASDAQ:INZY) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $14.00 price target on the stock. This represents a 198.5% upside from the current price of $4.69.
- Intuitive Surgical (NASDAQ:ISRG) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $500.00 price target on the stock. This represents a 23.6% upside from the current price of $404.63.
- Janux Therapeutics (NASDAQ:JANX) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $47.00 price target on the stock. This represents a 6.1% downside from the current price of $50.03.
- Johnson & Johnson (NYSE:JNJ) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $160.00 price target on the stock. This represents a 10.1% upside from the current price of $145.26.
- Medtronic (NYSE:MDT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $83.00 price target on the stock. This represents a 2.6% upside from the current price of $80.89.
- Molina Healthcare (NYSE:MOH) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $405.00 price target on the stock. This represents a 29.3% upside from the current price of $313.34.
- Novo Nordisk A/S (NYSE:NVO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $156.00 price target on the stock. This represents a 16.7% upside from the current price of $133.67.
- Novartis (NYSE:NVS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $120.00 price target on the stock. This represents a 18.9% upside from the current price of $100.91.
- NOVONIX (NASDAQ:NVX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $4.00 price target on the stock. This represents a 102.0% upside from the current price of $1.98.
- Oscar Health (NYSE:OSCR) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $28.00 price target on the stock. This represents a 41.2% upside from the current price of $19.83.
- Wag! Group (NASDAQ:PET) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $4.00 price target on the stock. This represents a 156.4% upside from the current price of $1.56.
- PNM Resources (NYSE:PNM) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $38.00 price target on the stock. This represents a 2.7% upside from the current price of $37.01.
- Insulet (NASDAQ:PODD) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $235.00 price target on the stock. This represents a 30.9% upside from the current price of $179.54.
- Privia Health Group (NASDAQ:PRVA) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 32.8% upside from the current price of $17.32.
- Roche (OTCMKTS:RHHBY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating on the stock.The current price is $31.33.
- Vivid Seats (NASDAQ:SEAT) is now covered by analysts at DA Davidson. They set a "buy" rating and a $7.00 price target on the stock. This represents a 43.7% upside from the current price of $4.87.
- Solventum (NYSE:SOLV) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "sell" rating and a $54.00 price target on the stock. This represents a 6.3% downside from the current price of $57.64.
- Stryker (NYSE:SYK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $372.00 price target on the stock. This represents a 8.9% upside from the current price of $341.69.
- Tenet Healthcare (NYSE:THC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $153.00 price target on the stock. This represents a 13.7% upside from the current price of $134.51.
- TriSalus Life Sciences (NASDAQ:TLSI) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $12.00 price target on the stock. This represents a 59.6% upside from the current price of $7.52.
- TriSalus Life Sciences (NASDAQ:TLSI) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $12.00 price target on the stock. This represents a 59.6% upside from the current price of $7.52.
- Tandem Diabetes Care (NASDAQ:TNDM) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $60.00 price target on the stock. This represents a 16.0% upside from the current price of $51.74.
- Universal Health Services (NYSE:UHS) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $198.00 price target on the stock. This represents a 6.9% upside from the current price of $185.22.
- UnitedHealth Group (NYSE:UNH) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $597.00 price target on the stock. This represents a 23.6% upside from the current price of $483.20.
- Zimmer Biomet (NYSE:ZBH) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $129.00 price target on the stock. This represents a 12.2% upside from the current price of $114.95.
- View today's most recent analysts' new coverage at MarketBeat.com
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL  |
|
| Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
| VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
| JOIN NOW |
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: Write this ticker symbol down… |
|
No comments:
Post a Comment